Dab2, a negative regulator of DC immunogenicity, is an attractive molecular target for DC-based immunotherapy.
about
Disabled-2 is a negative immune regulator of lipopolysaccharide-stimulated Toll-like receptor 4 internalization and signaling.SH2 domain-containing adaptor protein B expressed in dendritic cells is involved in T-cell homeostasis by regulating dendritic cell-mediated Th2 immunity.Quercetin protects against atherosclerosis by inhibiting dendritic cell activation.Disabled-2: A modular scaffold protein with multifaceted functions in signaling.Functional links between Disabled-2 Ser723 phosphorylation and thrombin signaling in human platelets.Immune Cell Metabolism in Tumor Microenvironment.
P2860
Dab2, a negative regulator of DC immunogenicity, is an attractive molecular target for DC-based immunotherapy.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Dab2, a negative regulator of ...... et for DC-based immunotherapy.
@ast
Dab2, a negative regulator of ...... et for DC-based immunotherapy.
@en
type
label
Dab2, a negative regulator of ...... et for DC-based immunotherapy.
@ast
Dab2, a negative regulator of ...... et for DC-based immunotherapy.
@en
prefLabel
Dab2, a negative regulator of ...... et for DC-based immunotherapy.
@ast
Dab2, a negative regulator of ...... et for DC-based immunotherapy.
@en
P2093
P2860
P1433
P1476
Dab2, a negative regulator of ...... et for DC-based immunotherapy.
@en
P2093
Md Salahuddin
Md Selim Ahmed
Mohammad Alam Miah
Se Eun Byeon
Sung-Soo Park
Yideul Jeong
Yong-Soo Bae
P2860
P304
P356
10.4161/2162402X.2014.984550
P577
2015-01-01T00:00:00Z